Author reply to: Hepatitis B reactivation in chronic hepatitis C patients during treatment with ledipasvir and sofosbuvir
Antivir Ther
.
2018;23(3):284.
doi: 10.3851/IMP3127.
Authors
Edward J Gane
1
2
,
Robert H Hyland
3
,
Di An
3
,
Evguenia S Svarovskaia
3
,
Diana Brainard
3
,
John G McHutchison
3
Affiliations
1
Auckland Clinical Studies, Auckland, New Zealand.
2
New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand.
3
Gilead Sciences, Inc., Foster City, CA, USA.
PMID:
28296642
DOI:
10.3851/IMP3127
No abstract available
Publication types
Letter
Comment
MeSH terms
Benzimidazoles
Coinfection*
Fluorenes
HIV Infections*
Hepatitis B virus
Hepatitis B*
Hepatitis C, Chronic*
Humans
Sofosbuvir
Substances
Benzimidazoles
Fluorenes
ledipasvir
Sofosbuvir